This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,922.68 firm fixed-price delivery order is for the supply of 4,566,735,502 units of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The contract has an ultimate completion date of December 17, 2024.
Amerisourcebergen is the prime contractor and has no set-aside designation, indicating an open competition. The company maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
These contract awards demonstrate Amerisourcebergen's significant role in supplying essential pharmaceutical and medical commodities to various federal agencies, particularly the DLA, which is responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces.
Generated 3/17/25, 10:05 AM